Drug Profile
Diphtheria tetanus vaccine intranasal
Latest Information Update: 25 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diphtheria; Tetanus